Analog Devices and TWAICE Work Together to Advance Battery Lifecycle Optimization
Battery analytics software expert TWAICE today announced a collaboration with Analog Devices, Inc., a global semiconductor and system solutions company, to tackle the challenges of battery lifecycle optimization. The combination of Analog Devices’ sensor technology and wireless connectivity with TWAICE’s battery analytics software will benefit customers in the mobility and energy sectors. The alliance will be instrumental in significantly reducing warranty risks and recalls, optimizing battery life, and enhancing battery value.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210902005016/en/
TWAICE Battery Testing Laboratory in Munich, Germany. Photo: TWAICE
Analog Devices is a global leader in battery management systems, and high-performance analog, mixed-signal, and digital signal processing solutions. The collaboration with the software company TWAICE, whose platform provides end-to-end battery analytics solutions, will enable the optimization of the entire battery lifecycle.
Mobility is at an inflection point, with electrified powertrains replacing combustion engines. Battery reliability and economics are critical in the widespread deployment of renewable energies and electric vehicles. Battery performance and lifespan play a key role in the sustainability of solutions they are deployed in, yet the assessment thereof is often challenging. “Precision data combined with advanced predictive battery analytics will shed light into the darkness, which is crucial in unlocking as yet undiscovered potential along the entire value chain," said Dr. Stephan Rohr, Co-CEO of TWAICE.
“The battery is the energy source for every electric vehicle, and it is also a valuable asset,” said Patrick Morgan, Vice President of Automotive at Analog Devices. “Together with TWAICE, we are delivering innovative holistic solutions across battery lifetimes that create significant value for our customers and support a circular economy.”
The goal of the collaboration is to provide a holistic lifecycle solution for automakers with integrated hardware and software. Accurate battery measurements provided through a wireless battery management system form the basis. Analog Devices’ sensor technology provides data, and a quality thereof previously unavailable. TWAICE can generate crucial insights into the battery performance desired by companies around the globe. The resulting forecasts enable qualified statements at any point in the battery lifecycle regarding its value and usability.
About Analog Devices Inc.
Analog Devices (ADI), headquartered in Norwood, Massachusetts, is a global leader in the design, manufacture and marketing of a broad portfolio of high-performance analog, mixed-signal, DSP circuits and microchips used in virtually all types of electronic devices. With over 55 years of market experience, 16,000 employees worldwide today, over 4,700 patents and 125,000 customers in instrumentation, automation, communications, healthcare, automotive and numerous other industries, Analog Devices is dedicated to solving technical challenges associated with signal processing in electronic devices. More at www.analog.com.
About TWAICE
TWAICE provides predictive analytics software that optimizes both the development and operation of lithium-ion batteries. As the leading provider of battery analytics software to global electric vehicle and energy companies, TWAICE increases the longevity, efficiency and sustainability of products that drive tomorrow's economy. More at www.twaice.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005016/en/
Contact information
Anna Lossmann
press@twaice.com
PR13
twaice@pr13.de
+49 40 21993366
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SBC Medical Group Enters the Thai Market through Partnership with BLEZ14.11.2025 14:47:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that it has entered into a Consulting Agreement with BLEZ ASIA Co., Ltd. (Headquarters: Bangkok, Thailand; CEO: Naoki Iida; “BLEZ”), which operates more than 20 pharmacies and clinics in Thailand and is widely trusted by both Japanese expatriates and local patients. The partnership is a key component of SBC’s broader Asia strategy and represents a significant step toward full-scale entry into the rapidly growing Thai aesthetic medicine market. Under the agreement, SBC will provide comprehensive management support to a new clinic focused primarily on dermatological treatments such as pigmentation and spot removal, which BLEZ is preparing to open in Bangkok. SBC will advise on clinical protocol development, aligned with SBC’s quality standards, and assist in selecting me
SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results14.11.2025 14:00:00 EET | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced its financial results for the third quarter of fiscal year 2025 (three months ended September 30, 2025) and for the third quarter cumulative of fiscal year 2025 (Year-to-Date 2025, nine months ended September 30, 2025) Third Quarter 2025 Highlights Total revenues were $43 million, representing an 18% year-over-year decrease. Income from operations was $16 million, representing a 15% year-over-year increase. Net Income attributable to SBC Medical Group was $13 million , representing an 353% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.12 for the three months ended September 30, 2025, compared to $0.03 in the same period of 2024. EBITDA1, which
Ant Group Chairman Eric Jing Outlines Strategy for Inclusive AI, Collaboration on Tokenised Settlement14.11.2025 12:15:00 EET | Press release
Eric Jing, Chairman of Ant Group, said the company's focus is on putting new payment and operation tools powered by AI and tokenisation technology in the hands of SMEs, to fully embrace the next wave of global productivity revolution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251114239737/en/ Ant Group Chairman Eric Jing (second from right) shares insights during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on November 14, 2025. “We are passionate about using frontier technology to support SMEs and the use of AI will really uplift inclusion,” Jing said during a panel discussion titled “Steering the Global Future” during the Singapore FinTech Festival on November 14, 2025. Jing was joined by Agustín Carstens, Former General Manager, Bank for International Settlements (BIS); Ravi Menon, Chairman of the Board of Directors, Global Finance & Technology Network (GFTN); Ambassado
Allianz Achieves Record Results and Expects a Full-Year Operating Profit of at Least 17 Billion Euros14.11.2025 08:16:00 EET | Press release
3Q 2025 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251113803211/en/ Oliver Bäte, Chief Executive Officer of Allianz SE Double-digit growth in operating profit and shareholders’ core net incomeTotal business volume rises 5.21 percent with contributions from all segments Operating profit increases 12.6 percent to 4.4 billion euros, with particular strong contribution from the Property-Casualty segment Shareholders’ core net income advances by 12.7 percent and reaches 2.9 billion euros 9M 2025 Continued strong and diversified growth across our businessesand record operating profitTotal business volume rises 8.5 1 percent and reaches 141.2 billion euros with contributions from all segments Operating profit increases 10.4 percent to 13.1 billion euros, our highest nine-month operating profit ever, reaching 82 percent of our full-year outlook midpoint Shareholders’ core net income advances 10.5 percent to 8.4 billion euros. Ad
Galderma Completes Successful Placement of CHF 175 Million Bond14.11.2025 08:00:00 EET | Press release
NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche CHF 175 million Swiss franc-denominated bond. The bond has a maturity of 5 years and carries a fixed-rate annual coupon of 0.9425%. Net proceeds from the transaction will be used to partially refinance Galderma’s existing bank term loan issued at its initial public offering (IPO) in March 2024, as well as for general corporate purposes. This marks the company’s third CHF-bond issuance since listing. The new bond will be listed on the SIX Swiss Exchange, with the settlement date expected on December 10, 2025. BNP Paribas and UBS jointly led the transaction. Galderma is rated BBB (stable outlook) by Fitch. The same rating is also expected to be assigned to the new bond. The successful issuance is leverage-ne
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom